The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index; 2 of the 14 sources its claims cite were checked for support.
Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization
Open accessAbstract
BACKGROUND: WHO, as requested by its member states, launched the Expanded Programme on Immunization (EPI) in 1974 to make life-saving vaccines available to all globally. To mark the 50-year anniversary of EPI, we sought to quantify the public health impact of vaccination globally since the programme's inception. METHODS: In this modelling study, we used a suite of mathematical and statistical models to estimate the global and regional public health impact of 50 years of vaccination against 14 pathogens in EPI. For the modelled pathogens, we considered coverage of all routine and supplementary vaccines delivered since 1974 and estimated the mortality and morbidity averted for each age cohort relative to a hypothetical scenario of no historical vaccination. We then used these modelled outcomes to estimate the contribution of vaccination to globally declining infant and child mortality rates over this period. FINDINGS: Since 1974, vaccination has averted 154 million deaths, including 146 million among children younger than 5 years of whom 101 million were infants younger than 1 year. For every death averted, 66 years of full health were gained on average, translating to 10·2 billion years of full health gained. We estimate that vaccination has accounted for 40% of the observed decline in global infant mortality, 52% in the African region. In 2024, a child younger than 10 years is 40% more likely to survive to their next birthday relative to a hypothetical scenario of no historical vaccination. Increased survival probability is observed even well into late adulthood. INTERPRETATION: Since 1974 substantial gains in childhood survival have occurred in every global region. We estimate that EPI has provided the single greatest contribution to improved infant survival over the past 50 years. In the context of strengthening primary health care, our results show that equitable universal access to immunisation remains crucial to sustain health gains and continue to save future lives from preventable infectious mortality. FUNDING: WHO.
Overview
CoChat Summary
TL;DR
Modelling 50 years of the WHO Expanded Programme on Immunization estimates that vaccination against 14 pathogens averted 154 million deaths from 1974 to 2024, including 146 million in children younger than 5 years, and gained 10·2 billion years of full health. Vaccination accounted for 40% of the global decline in infant mortality, with measles vaccination the single greatest contributor.
Key findings
- Vaccination averted 154 million deaths, including 146 million in children younger than 5 years and 101 million in infants younger than 1 year; 9·0 billion life-years and 10·2 billion years of full health were gained. For each death averted, an average of 58 years of life and 66 years of full health were gained.
- Measles vaccination accounted for 93·7 million lives saved (60·8%) of the 154·0 million total. Poliomyelitis vaccination averted 1% of deaths but accounted for 0·8 billion (7·8%) of the 10·2 billion years of full health gained.
- Vaccination was estimated to be directly responsible for 40% of the global decline in infant mortality, varying from 21% in the Western Pacific region to 52% in the African region. In 2024, children aged 10 years were approximately 44% more likely to survive to their next birthday than with no historical vaccination; individuals aged 25 years were 35% more likely, and those aged 50 years were 16% more likely.
- Global coverage with a third dose of diphtheria–tetanus–pertussis vaccine increased from less than 5% in 1974 to 86% in 2019 before the COVID-19 pandemic, and was 84% at the time of the study.
Methods
- Modelling study estimating deaths averted, life-years gained, and years of full health gained from vaccination against 14 pathogens in 194 WHO member states between June 1, 1974, and May 31, 2024, through routine and supplementary immunisation activities, relative to a hypothetical scenario of no historical vaccination.
- The analysis synthesised results of 22 models using three modelling forms: dynamic transmission models for measles and poliomyelitis; extended Vaccine Impact Modelling Consortium transmission models for *H influenzae* type B, hepatitis B, Japanese encephalitis, invasive pneumococcal disease, rotavirus, and rubella; and upgraded static disease burden models for diphtheria, tetanus, pertussis, and tuberculosis. Age-specific coverage was drawn from WHO Immunization dashboard, WHO Supplementary Immunization Activities Database, WHO Polio Information System, and VIMC estimates; 24 vaccine activities were evaluated.
- Regression-based imputation and functional fitting with Markov chain Monte Carlo and Akaike Information Criterion model selection were used to extrapolate impact to countries and time periods without direct model estimates. Primary outcomes were deaths averted, years of life gained, years of full health gained, and the proportion of infant mortality reduction attributable to vaccination, with secondary evaluation by WHO region and World Bank income stratum.
Limitations
- The paper states that the calendar-year approach does not fully account for post-2024 lifetime vaccination impacts, implying a substantial underestimate for diseases such as hepatitis B; HPV was excluded because of incomparability of timeframe. The analysis also excludes vaccines against COVID-19, influenza, HPV, outbreak vaccines such as cholera or Ebola, vaccines targeting disease in adult life, and vaccines used largely in high-income settings such as varicella, herpes zoster, or mumps; the counterfactual assumed a smallpox-free world, so smallpox eradication benefits were not counted.
- The paper states that double counting is a limitation but estimates it would have only a small (0·01%) effect; findings are presented at global and regional resolution, limiting geographical conclusions; uncertainty propagation was not possible for all hierarchical models or inputs; and posterior credible intervals had arbitrarily predefined widths and should not be interpreted as bounds for final outcomes.
- The text makes evident further limitations: the authors describe the analysis as a minimum conservative estimate because it excludes possible heterologous or non-specific vaccine effects, downstream effects on non-communicable disease mortality, and broader economic or community development gains. The text also contains an internal numerical inconsistency, reporting 10·2 billion years of full health in the abstract and results but referring later to 10·8 billion healthy life-years gained.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
2 Valid · 2 Not valid · 8 Not checked · 77 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Measles vaccination has been the single greatest contributor and is likely to remain so.18, 23”
§ Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization > Discussion
What the sources say
- Supportedcites [18] Toor J Echeverria-Londono S Li X Lives saved with vaccination for 10 pathogens across 12 countries in a pre-COVID-19 world eLife 10 2021 10 PMC8277373 34253291 source
The Results (Impact by year of vaccination; page not provided) identify measles as having the largest estimated impact on deaths averted among the ten pathogens over 2000–2030. The Discussion says that, under the default forecast through 2030, measles is predicted to produce the greatest reduction in deaths. The prediction is conditional on that forecast, not an indefinite projection. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [23] Carter A Msemburi W Sim SY Modeling the impact of vaccination for the Immunization Agenda 2030: deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030 Vaccine 2023 published online Aug 1. 10.1016/j.vaccine.2023.07.033 37537094 source
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Since 1974, vaccination has averted 154 million deaths,”
- Also stated in: § Findings · plain
“Since 1974, vaccination has averted 154 million deaths, including 146 million among children younger than 5 years of whom 101 million were infants younger than 1 year.”
§ Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization > Abstract > Findings
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Findings · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Since 1974, vaccination has averted 154 million deaths, including 146 million among children younger than 5 years of whom 101 million were infants younger than 1 year.”
§ Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization > Abstract > Findings
plainstates a causen = 146- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For every death averted, 66 years of full health were gained on average, translating to 10·2 billion years of full health gained.”
§ Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization > Abstract > Findings
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We estimate that vaccination has accounted for 40% of the observed decline in global infant mortality, 52% in the African region.”
§ Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization > Abstract > Findings
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
48 more claims
Create a free account to see all 89 claims and every source verdict.
- Probably not a substantial claim. 23
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, the Expanded Programme on Immunization (EPI) marks its 50th anniversary in 2024 and a retrospective assessment of impact estimated that 40% of the post-1974 decline in infant mortality resulted from the EPI.81”
From Global health 2050: the path to halving premature death by mid-century (2024) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization > Results
“with 0·8 billion (7·8%) of the 10·2 billion years of full health gained attributable to poliomyelitis cases averted.”
§ Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization > Discussion
“Vaccination against poliomyelitis has had a modest impact on mortality, averting 1% of deaths, but has led to substantial public health gains by reducing poliomyelitis-induced paralysis, accounting for 8% of the 10·8 billion healthy life-years gained.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization > Discussion
“accounting for 8% of the 10·8 billion healthy life-years gained.”
§ Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization > Discussion
“10·2 billion healthy years of life have been gained due to vaccination.”
Citations
Cites
Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30068-4 · Cited by 1,138 · cited 1×
“18,23,32 This imperative is highly dependent on achieving post-COVID-19 pandemic recovery and restoration of the trajectory to Immunization Agenda 2030 targets; achieving and maintaining universally high coverage with measles-containing vaccines (a principle aim of the Big Catch-up initiative;…”
BackgroundSelf-citationImmunization agenda 2030: A global strategy to leave no one behind
(2024) · Vaccine · doi:10.1016/j.vaccine.2022.11.042 · Cited by 372
The broader economic impact of vaccination: reviewing and appraising the strength of evidence
Jit, M., Hutubessy, R., Png, M. E., Sundaram, N., Audimulam, J., Salim, S., & Yoong, J. (2015) · BMC Medicine · doi:10.1186/s12916-015-0446-9 · Cited by 153 · cited 1×
“30 We also did not include possible heterologous effects of vaccines on epitopically non-specific immune training or other potential mechanisms.”
BackgroundSelf-citationCarter, A., Msemburi, W., Sim, S. Y., Gaythorpe, K. A. M., Lambach, P., Lindstrand, A., & Hutubessy, R. (2024) · Vaccine · doi:10.1016/j.vaccine.2023.07.033 · Cited by 121 · cited 4×
“18 Finally, published static disease burden models for diphtheria, tetanus, pertussis, and tuberculosis were upgraded (appendix pp 23–31).”
BackgroundMethodInfluentialSelf-citationVerguet, S., Johri, M., Morris, S. K., Gauvreau, C. L., Jha, P., & Jit, M. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.11.050 · Cited by 106 · cited 1×
“20,21 For poliomyelitis we ran novel simulations of an existing dynamic model.”
MethodSelf-citationLives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world
Toor, J., Echeverria-Londono, S., Li, X., Abbas, K., Carter, E. D., Clapham, H. E., Clark, A., de Villiers, M. J., Eilertson, K., Ferrari, M., et al. (2021) · eLife · doi:10.7554/elife.67635 · Cited by 97 · cited 4×
“18 Finally, published static disease burden models for diphtheria, tetanus, pertussis, and tuberculosis were upgraded (appendix pp 23–31).”
BackgroundMethodInfluentialSelf-citationClark, R. A., Mukandavire, C., Portnoy, A., Weerasuriya, C. K., Deol, A., Scarponi, D., Iskauskas, A., Bakker, R., Quaife, M., Malhotra, S., et al. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00045-1 · Cited by 63
Self-citationPolio by the Numbers—A Global Perspective
Badizadegan, K., Kalkowska, D. A., & Thompson, K. M. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac130 · Cited by 35 · cited 1×
“22 Second, we extended a suite of VIMC transmission models for H influenzae type B, hepatitis B, Japanese encephalitis, invasive pneumococcal disease, rotavirus, and rubella, which estimated vaccine impact for 110 countries (fewer for meningitis A and yellow fever) from 2000 to 2024, by…”
MethodSelf-citationEilertson, K. E., Fricks, J., & Ferrari, M. J. (2019) · Statistics in Medicine · doi:10.1002/sim.8290 · Cited by 32 · cited 2×
“20,21 For poliomyelitis we ran novel simulations of an existing dynamic model.”
MethodSelf-citationHow can the public health impact of vaccination be estimated?
Londono, S. E., Li, X., Toor, J., de Villiers, M. J., Nayagam, S., Hallett, T. B., Abbas, K., Jit, M., Klepac, P., Jean, K., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-12040-9 · Cited by 30 · cited 2×
“18 Finally, published static disease burden models for diphtheria, tetanus, pertussis, and tuberculosis were upgraded (appendix pp 23–31).”
BackgroundSelf-citation
Cited by
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Pardi, N., & Krammer, F. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01042-y · Cited by 229
“Vaccines have had a significant impact on the reduction of morbidity and mortality caused by various pathogens 1 .”
Progress Toward Measles Elimination — Worldwide, 2000–2023
Minta, A. A., Ferrari, M., Antoni, S., Lambert, B., Sayi, T. S., Hsu, C. H., Steulet, C., Gacic-Dobo, M., Rota, P. A., Mulders, M. N., et al. (2024) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7345a4 · Cited by 201
Self-citationHaeuser, E., Byrne, S., Nguyen, J., Raggi, C., McLaughlin, S. A., Bisignano, C., Harris, A. A., Smith, A. E., Lindstedt, P. A., Smith, G., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01037-2 · Cited by 143
Self-citationGlobal health 2050: the path to halving premature death by mid-century
Jamison, D. T., Summers, L. H., Chang, A. Y., Karlsson, O., Mao, W., Norheim, O. F., Ogbuoji, O., Schäferhoff, M., Watkins, D., Adeyi, O., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01439-9 · Cited by 125
mRNA vaccine sequence and structure design and optimization: Advances and challenges
Jin, L., Zhou, Y., Zhang, S., & Chen, S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108015 · Cited by 110
Metadata
- Authors
- Shattock, A. J., Johnson, H. C., Sim, S. Y., Carter, A., Lambach, P., Hutubessy, R. C. W., Thompson, K. M., Badizadegan, K., Lambert, B., Ferrari, M. J., Jit, M., Fu, H., Silal, S. P., Hounsell, R. A., White, R. G., Mosser, J. F., Gaythorpe, K. A. M., Trotter, C. L., Lindstrand, A., O'Brien, K. L., & Bar-Zeev, N.
- Affiliations
- Swiss Tropical and Public Health Institute (CH)
- University of Cambridge (GB)
- London School of Hygiene & Tropical Medicine (GB)
- University of Washington (US)
- Pennsylvania State University (US)
- University of Cape Town (ZA)
- ORCID
- Shattock, Andrew J
- Johnson, Helen C
- Sim, So Yoon
- Carter, Austin
- Lambach, Philipp
- Hutubessy, Raymond C W
- Thompson, Kimberly M
- Badizadegan, Kamran
- Lambert, Brian
- Ferrari, Matthew J
- Jit, Mark
- Fu, Han
- Silal, Sheetal P
- Hounsell, Rachel A
- White, Richard G
- Mosser, Jonathan F
- Gaythorpe, Katy A M
- Trotter, Caroline L
- Lindstrand, Ann
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2024-05
- Volume
- 403
- Issue
- 10441
- Pages
- 2307-2316
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC11140691
- OpenAlex
- W4396571207
- Cited by
- 655
- References
- 12
- Citations by year
- 2026: 324 · 2025: 268 · 2024: 63
- FWCI
- 295.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/3.0/igo/ (vor)
- Locations
- The Lancet (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- London School of Economics and Political Science Research Online (London School of Economics and Political Science) (acceptedVersion)
- London School of Economics and Political Science Theses Online (London School of Economics and Political Science) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by)
- Funders
- World Health Organization (201910)
- Bill and Melinda Gates Foundation (OPP1157270, INV-034218, INV-009125)
- Topics
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- Expanded Programme on Immunization, vaccine impact, mortality averted, child mortality decline, infant mortality, life-years gained, child survival, vaccination coverage, global health impact
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Humans, Infant, Infant Mortality, Infant, Newborn, Middle Aged, Public Health, Vaccination, Global Health, Models, Statistical, Immunization Programs, Child Mortality, History, 20th Century, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization. https://app.cochat.ai/papers/10.1016/s0140-6736(24)00850-x
- The paper
- Shattock, A. J., Johnson, H. C., Sim, S. Y., Carter, A., Lambach, P., Hutubessy, R. C. W., Thompson, K. M., Badizadegan, K., Lambert, B., Ferrari, M. J., Jit, M., Fu, H., Silal, S. P., Hounsell, R. A., White, R. G., Mosser, J. F., Gaythorpe, K. A. M., Trotter, C. L., Lindstrand, A., . . . Bar-Zeev, N. (2024). Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization. The Lancet. https://doi.org/10.1016/s0140-6736(24)00850-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.